Related Experiment Video
Updated: Aug 12, 2026
Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
Published on: April 18, 2015
Contrast-enhanced MR imaging of the pancreas
1Department of Radiology, University of North Carolina at Chapel Hill, USA.
Abstract:
Recent MR techniques such as breath-hold imaging, fat suppression, and dynamic imaging after intravenous administration of gadolinium chelates have reduced artifacts in the abdomen, resulting in an increased role of MR imaging in the evaluation of pancreatic disease. The extracellular contrast agent gadolinium chelate has been shown to enhance normal pancreatic tissue in a homogeneous fashion. Contrast between normal pancreatic tissue and tumor tissue on T1-weighted images may be improved after administration of gadolinium. Because of the lesser vascularization of pancreatic ductal cancers as compared to the normal glandular tissue, the differences in signal intensity are often greatest in the capillary phase immediately after contrast administration. In addition, the hypervascular nature of islet cell tumors, results in good definition of primary tumor and liver metastases on immediate post-gadolinium images.
Insights
Magnetic resonance (MR) imaging advancements improve pancreatic disease evaluation. Gadolinium contrast agents enhance tissue visualization, aiding in the detection of pancreatic tumors and metastases.
Area of Science:
- Radiology
- Medical Imaging
- Gastroenterology
Background:
- Abdominal MR imaging has evolved with techniques like breath-hold imaging and fat suppression.
- These advancements reduce artifacts, increasing MR's utility in diagnosing pancreatic conditions.
Purpose of the Study:
- To highlight the role of MR imaging with gadolinium contrast in evaluating pancreatic diseases.
- To explain how contrast enhancement aids in differentiating normal pancreatic tissue from tumors.
Main Methods:
- Utilizing recent MR techniques including breath-hold imaging and fat suppression.
- Administering intravenous gadolinium chelates as extracellular contrast agents.
- Performing dynamic imaging in the capillary phase post-contrast administration.
Main Results:
- Gadolinium chelates homogeneously enhance normal pancreatic tissue.
- Improved contrast between normal and tumor tissue observed on T1-weighted images.
- Pancreatic ductal cancers, less vascularized than normal tissue, show signal intensity differences greatest in the capillary phase.
- Hypervascular islet cell tumors and liver metastases are well-defined on immediate post-gadolinium images.
Conclusions:
- Advanced MR imaging with gadolinium contrast significantly improves the evaluation of pancreatic diseases.
- Contrast-enhanced MR imaging is crucial for differentiating pancreatic tumors from normal tissue and identifying metastases.
